Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 1520-7552, Iss. 7, 2015-10 ,pp. : 672-679

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between Optimum Mini‐doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes – A Simulation Study

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 122, Iss. 3, 2018-03 ,pp. : 322-330

John Wiley & Sons Inc

Access to resources Recommend Favorite

Growth hormone response to the insulin tolerance and clonidine tests in type 1 diabetes

By Almqvist E G   Groop L C   Manhem P J  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 59, Iss. 5, 1999-10 ,pp. : 375-382

Informa Healthcare

Access to resources Recommend Favorite

Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes

By Hayes Risa P.   Muchmore Douglas   Schmitke Jennifer  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 435-442

Informa Healthcare

Access to resources Recommend Favorite

Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 419-426

John Wiley & Sons Inc

Access to resources Recommend Favorite